Alectinib,Atezolizumab,Pemetrexed,Cisplatin,Carboplatin,Gemcitabine,Entrectinib,Cobimetinib,Vemurafenib,Bevacizumab,RG6330,Docetaxel
Roche
['biomarker', 'nsclc', 'lung', 'atezo', 'sclc']
in a phase 3 trial, the selection of #nsclc patients based on high blood-based tumor mutation burden did not improve clinical response to #atezolizumab, as compared with chemotherapy #biomarker #liquidbiopsy #lungcancer #aacr23 
Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.